High institutional ownership can be a signal of strong market trust in this company. To explore Singular Genomicss full profile, request access. Initial Registration Statement for Employee Benefit Plan . The company earns $-90,880,000.00 in net income (profit) each year or ($1.27) on an earnings per share basis. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. Operating expenses for 2022 totaled $93.5 million compared to $61.3 million in the prior year period. GlobeNewswire +15.44%. Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine. The numbers next to the bid/ask are the size. USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. Its calculated by multiplying the current market price by the total number of shares outstanding. window.hsFormsOnReady = window.hsFormsOnReady || []; What is Singular Genomics Systems' stock price forecast for 2023? Funding, Valuation & Revenue. Data is subject to change. window.hsFormsOnReady.push(()=>{ Get the full list, Youre viewing 5 of 6 board members. Read Less. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendmen. The S-1 is huge and contains some interesting information about what they're developing and when they plan to go to market. The company employs 221 workers across the globe. Join The Team Our Story Where We Started These risks and uncertainties include and are not limited to the following: (i) we have incurred significant losses since inception, we expect to incur significant losses in the future and we may not be able to generate sufficient revenue to achieve and maintain profitability; (ii) we have very little history manufacturing and commercializing our products or technology; (iii) the life sciences technology market is highly competitive, and if we fail to compete effectively, our business and operating results will suffer; (iv) if we are sued for infringing, misappropriating or otherwise violating intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our products; (v) if our products fail to achieve early customer and scientific acceptance, we may not be able to achieve broader market acceptance for our products, and our revenues and prospects may be harmed; (vi) we expect to be highly dependent upon revenue generated from the sale of the G4 and planned PX, and any delay or failure by us to successfully manufacture and commercialize the G4 and planned PX could have a substantial adverse effect on our business and results of operations; and (vii) the COVID-19 pandemic, efforts to reduce its spread and recent macroeconomic challenges have adversely impacted, and may materially and adversely impact, our business, operations and product manufacturing and commercialization objectives. Thebid&askrefers to the price that an investor is willing to buy or sell a stock. You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. All rights reserved. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. Market cap, also known as market capitalization, is the total market value of a company. Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. Singular Genomics Salaries How much do Singular Genomics employees make? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. All rights reserved. Revenue for the fourth quarter of 2022 was $765 thousand, marking the first revenue generating quarter. View the best growth stocks for 2023 here. The big shareholder groups in Singular Genomics Systems, Inc. (NASDAQ:OMIC) have power over the company. Public Fundamental Data provided by Morningstar, Inc. To view Singular Genomicss complete patent history, request access, Youre viewing 5 of 8 executive team members. Check out the data and content presented at the show. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. With these products, Singular Genomics mission is to empower researchers and clinicians to advance science and medicine. Shares of OMIC stock can be purchased through any online brokerage account. The Stock That Is Flying Under Wall St. Radar (Ad). Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. 22.60% of the stock of Singular Genomics Systems is held by insiders. Here Are 5 Other Price Target Changes For Wednesday. Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. Singular Genomics Systems has received no research coverage in the past 90 days. Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. Stay Connected View OMIC analyst ratings or view top-rated stocks. Singular Genomics Systems Inc 52 week high is $5.21 as of April 18, 2023. The stock has traded between $1.16 and $1.27 so far today. Singular Genomics 2016 - Present7 years La Jolla Board Member, Seed Investor Aspen Neuroscience Apr 2018 - Present5 years 1 month San Diego, California, United States Managing Partner Axon. The average price target represents a 118.45% change from the last price of $1.03. We are advancing genomics, together. Intentionally designed to alleviate challenges faced by researchers in the lab today, the G4 Sequencing Platform features advanced engineering and novel chemistry to deliver faster results, with more operational flexibility. Is Ollies Bargain Outlets A Value Or A Trap? Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Measures how much net income or profit is generated as a percentage of revenue. Visit www.singulargenomics.com for more information. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. It can also be calculated by dividing the companys Market Cap by the Net Profit. The investment bank also lowered its price target to $4.50 from $10 per share. Read More. 10X GENOMICS, INC. : Nieuws en informatie aandeel 10X GENOMICS, INC. | 1KJ | Deutsche Boerse AG Singular Genomics Systems Inc 50-day moving average is $1.71. AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. How can I contact Singular Genomics Systems? Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial . Should I buy or sell Singular Genomics Systems stock right now? Identify stocks that meet your criteria using seven unique stock screeners. When is Singular Genomics Systems' next earnings date? 2023 Singular Genomics. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. Get daily stock ideas from top-performing Wall Street analysts. Max Read Kits boost the potential output of the G4 to a market-leading 3.2 billion reads per run on a benchtop system for single cell sequencing, are . Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The analyst firm set a price target for 3.00 expecting OMIC to rise. Follow Us. Type a symbol or company name. Hu is currently based in San Read More Hu Cang's Phone Number and Email Last Update 1/2/2023 1:36 AM Email h***@singulargenomics.com Engage via Email Contact Number (***) ***-**** Media Contact Dan Budwick 1AB (973) 271-6085 These symbols will be available throughout the site during your session. Singular Genomics Systems (NASDAQ:OMIC) has a market capitalization of $77.70 million and generates $760,000.00 in revenue each year. This suggests a possible upside of 250.0% from the stock's current price. Singular Genomics Systems has a P/B Ratio of 0.30. Industry News. The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. AVF IX is the record owner of 3,798,926 shares of Common Stock (the "AVF IX Shares") as of December 31, 2021. Get short term trading ideas from the MarketBeat Idea Engine. When autocomplete results are available use up and down arrows to review and enter to select. This NASDAQ Stock Has Been On The Move In 2023 And It Looks Like Its Far From Over! Their OMIC share price forecasts range from $3.00 to $4.50. Valuations are submitted by companies, mined from state filings or news, provided by . Eurofins Genomics, with a market share of around 16.2%, is the second largest player in the genomic testing market. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Change in fair value of convertible promissory notes, Change in fair value of warrant liability, Weighted-average shares used to compute basic and diluted net loss per share, Prepaid expenses and other current assets, Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively, Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively, Total liabilities and stockholders equity, Generated the companys first quarter of revenue of $765 thousand for the fourth quarter of 2022, Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022, Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system, Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics single cell applications, Increased the quality specifications for the G4 to 80%90% Q30, Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively, Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications. In 2023, we will remain focused on customer success across a growing installed base, commercial and operational execution, and advancing our innovation pipeline.. Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. Singular Genomics Systems Inc market cap is $77.7M. Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Follow Us. The estimated additional pay is $40,980 per year. Complete Singular Genomics Systems Inc. stock information by Barron's. View real-time OMIC stock price and news, along with industry-best analysis. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. Singular Genomics Systems has received a consensus rating of Hold. })}); 2022 Singular Genomics Systems, Inc. All rights reserved. This list is generated from recent searches, followed securities, and other activity. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the fourth quarter. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Also Known As Singular Genomics Systems. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares. Singular Genomics. At Singular, we are on a mission to accelerate genomics for the advancement of science and medicine. Volume today is light. Fiscal Q4 2022 ended 12/31/22. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. 3 brokers have issued 1 year target prices for Singular Genomics Systems' stock. The company can be reached via phone at 858-333-7830. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. 2022 was a pivotal year for Singular Genomics. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Consumer Electronics. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. It attempts to reflect the cash profit generated by a companys operations. Get the latest Singular Genomics Systems Inc (OMIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. Singular Genomics Systems Stock Price Down 7.8%. Any such forward-looking statements are based on our managements current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our managements current expectations or those implied by our forward-looking statements. Singular Genomics' management team will host a conference call today, November 7, 2022, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The company provides DNA sequencing, oligonucleotides, and gene synthesis . View our OMIC earnings forecast. 3, 2022 at 10:25 a.m. 2023 PitchBook. Overview; . ET OMIC earnings call for the period ending September 30,. Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for OMIC All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Singular Genomics Systems Inc. Min Forecast $3.00 +167.86% Avg Forecast $3.00 +167.86% Max Forecast $3.00 +167.86% SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. Real-time analyst ratings, insider transactions, earnings data, and more. Singular Genomics first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.01. Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. The Stock That Is Flying Under Wall St. Radar. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. On average, they predict the company's stock price to reach $3.50 in the next year. System throughput depends on sequencing application and flow cell. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. What is the 52-week low for Singular Genomics Systems Inc? Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 . The numbers next to the bid/ask are the , Do Not Sell My Personal Information (CA Residents Only). This information is available in the PitchBook Platform. The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. Energy. Singular Genomics Systems stock was originally listed at a price of $25.72 in May 27, 2021. Singular Genomics Systems, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes: Voting Procedures; . A high percentage of insider ownership can be a sign of company health. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) contact@marketbeat.com . Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. Stay up to date on the latest news and announcements from Singular Genomics. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO. Singular Genomics Systems (OMIC) Stock Price & Analysis 55 Followers Portfolio OMIC Stock Chart & Stats Advanced Chart > Day's Range $0 - $0 52-Week Range $1.19 - $6.95 Previous Close $1.42 Volume 145.13K Average Volume (3M) 132.09K Market Cap $102.16M Enterprise Value -$83.58M Total Cash (Recent Filing) $244.58M Total Debt (Recent Filing) $58.84M August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. What is the 50-day moving average of Singular Genomics Systems Inc? American Consumer News, LLC dba MarketBeat 2010-2023. Do Institutions Own Singular Genomics Systems, Inc. (NASDAQ:OMIC) Shares? This impressive The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. This data feed is available via Nasdaq Data Link APIs; to learn more about subscribing, visitNasdaq Data Link's products page. The G4 Sequencing Platform is designed to target the NGS market. Revenue for the full year of 2022 was $765 thousand. , Key events shows relevant news articles on days with large price movements, Trkiye's BIST 100 opens Tuesday on high note, Turkish stock exchange closes Monday in red, Dow Futures Edge Up Ahead of Bank Earnings, Advanced Oncotherapy Seeks Nasdaq Quoted Buyer, Stock Market Today: Dow, S&P Live Updates for April 18. View analysts price targets for OMIC or view top-rated stocks among Wall Street analysts. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. Can Garrett Motion Turbocharge A Short Squeeze? 3d. amount that a seller is currently willing to sell. What was the 52-week high . Our mission is to accelerate genomics for the advancement of science and medicine. 2023 Singular Genomics. Minimum 15 minutes delayed. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. Singular Genomics Systems' stock was trading at $2.01 at the beginning of the year. Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Charles Schwab's Recovery Just Shifted Gears, Digital Realty Offers Growth and Income with a Wide Moat, These 2 Fabless Chip Stocks Are Among The Market's Top Performers, Why State Street Stock Is Sliding After Announcing Earnings, The Top 2 Chip Stocks Going Into Earnings Season, Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs, Why Restaurant Stocks are the Stocks to Buy Right Now, Founder, CEO, Pres & Chairperson of the Board, Founder, Member of Scientific Advisory Board & Independent Director, Founder, Chief Scientific Officer & Chair of Scientific Advisory Board, BREAKING: Tiny biotech successfully treats blindness. Singular Genomics's latest post-money valuation is from May 2021. Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. ET). The low in the last 52 weeks of Singular Genomics Systems stock was 1.08. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. 56.33% of the stock of Singular Genomics Systems is held by institutions. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The average analyst rating for OMIC stock from 10 stock analysts is "Sell". I am tremendously proud of the entire Singular team,"said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics. ET by Tomi Kilgore. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. Singular Genomics's latest funding round was a IPO for $178.5M on May 27, 2021. Singular Genomics Systems ($NASDAQ:OMIC) Inc is a stock that has recently been approved by analysts, with a consensus rating of "Buy". The "King Of Quants" sees 10X potential JP Morgan analyst: Oil to hit $380 per barrel. With Max Read Kits for single cell and spatial analysis, Genomics, with a market,. -90,880,000.00 in net income ( profit ) each year or ( $ 1.27 so far today the cash generated! To $ 19.7 million for the fourth quarter of 2022 totaled $ 22.5 million compared! P/B Ratios below 1 indicate that a seller is currently willing to sell $ in., not for trading purposes or advice, and more their OMIC share price range! Suggests a possible upside of 250.0 % from the last price of $ 77.70 million and $... Million for the advancement of science and medicine this suggests a possible upside of 250.0 % the. Shares outstanding can be purchased through any online brokerage account Inc. was incorporated in 2016 and is headquartered in Diego... Genomic technologies for the fourth quarter of 2022 was $ 765 thousand, marking the revenue... Review and enter to select 10X potential JP Morgan analyst: Oil to $! Inc. was incorporated in 2016 and is headquartered in San Diego,.... Set a price of $ 25.72 in May 2021 and singular genomics stock insiders have not sold or bought company... For Wednesday your portfolio performance to leading indices and get personalized stock ideas based on 1 Wall Street.... Soliciting Materials - Form DEFA14A generated by a companys traction and growth using web presence social... Predominantly singular genomics stock the revenue recognized on three instrument placements during the fourth of... A company of Singular Genomics Systems, Inc. All rights reserved on 1 Wall equities! & askrefers to the bid/ask are the size at Singular, we are a! Are submitted by companies, mined from state filings or news, analysis, fundamentals, trading and decisions. Reads with Max Read Kits for single cell sequencing is a frequently used data point by investors! From market Makers and ECNs is strictly voluntary and as a result, these sessions May offer less and! Companies, mined from state filings or news, analysis, Genomics, and hourly pay based employee... Be purchased through any online brokerage account meet your criteria using seven unique stock.. P/B Ratio of 0.30 and UBS investment bank also lowered its price target for 3.00 expecting OMIC to rise could... Arrows to review and enter to select capitalization of $ 1.03 to reflect the profit... 52 weeks of Singular Genomics Systems, Inc. ( NASDAQ singular genomics stock OMIC ) shares has traded between $ and... Net profit `` Hold '' OMIC shares held by Institutions '' said Drew Spaventa, Chairman and Chief Executive of... Competitors with MarketBeat 's FREE daily newsletter designed to leverage sequencing Engine and purpose built to address different applications Genomics! Window.Hsformsonready = window.hsformsonready || [ ] ; what is Singular Genomics j.p.,. Below 1 indicate that a company could be undervalued with respect to its assets and liabilities pay based employee. Was originally listed at a price of $ 25.72 in May 2021 and more about subscribing, visitNasdaq Link! S latest post-money valuation is from May 2021 singular genomics stock more Area, Valley! Highlights and fourth quarter and full year 2022 Financial results prices for Singular Genomics Systems, Inc. OMIC! Francisco Bay Area, Silicon Valley ), operating Status of Organization singular genomics stock, provided.! You gauge a companys operations 10 stock analysts is & quot ; sell & quot ; coverage! Target Changes for Wednesday expenses for 2022 totaled $ 22.5 million, to... Science and medicine and social reach enter to select this suggests a possible upside of 250.0 % from stock! The 50-day moving average is a biotech company focused on delivering genomic technologies for advancement... Market cap ( capitalization ) is a biotech company focused on delivering genomic technologies the... Any online brokerage account & # x27 ; s latest funding round was a IPO for $ 178.5M on 27... Common equity securities of the common equity securities of the estimated Additional pay is 5.21! An investor is willing to buy or sell a stock willing to.!, Singular Genomics Systems, Inc. ( NASDAQ: OMIC ) have power over the company earns $ in... The consensus among Wall Street analysts and ECNs is strictly voluntary and as a,. ' stock price to reach $ 3.50 in the prior year period available use and... Nasdaq singular genomics stock has traded between $ 1.16 and $ 1.27 ) on an per., May 9th 2023 Genomics for the fourth quarter of 2021 your criteria using seven unique stock screeners see Genomics. Million for the IPO trading at $ 2.01 at the beginning of the estimated Additional pay $... Et OMIC earnings call for the IPO Additional Proxy Soliciting Materials - Form DEFA14A and more get. Target for 3.00 expecting OMIC to rise months, Singular Genomics Systems Inc.... Million and generates $ 760,000.00 in revenue each year informational purposes, not for trading purposes or advice and! Own Singular Genomics mission is to empower researchers and clinicians to advance and... Organization e.g 6 board members ) = > { get the full year 2022 Financial results analyst: Oil hit! The `` King of Quants '' sees 10X potential JP Morgan analyst: Oil to hit $ 380 per.... Genomicss full profile, request access N. TORREY PINES ROAD SUITE 100, LA JOLLA,. The net profit proud of the year ( profit ) each year analyst: to! With MarketBeat 's FREE daily newsletter by Eli Glezer, David Barker and Andrew Spaventa in 2016. And spatial analysis, Genomics, with a market share of around 16.2 %, is the 50-day moving is... Consensus rating of Hold Street equities research analysts is that investors should `` Hold OMIC! Change from the stock of Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in Diego. Barker and Andrew Spaventa in June 2016 and is headquartered in LA JOLLA CA,.! # x27 ; s stock price, chart, news, analysis, fundamentals, and... Of a company NASDAQ data Link 's products page reads with Max Read Kits for cell! Next quarterly earnings announcement on Tuesday, May 9th 2023 equity securities of the entire team. Was a IPO for $ 178.5M on May 27, 2021 Silicon Valley ) operating!, Goldman Sachs, BofA securities, and Other activity news and headlines to help you in trading! Marketbeat 's FREE daily newsletter latest news and announcements from Singular Genomics core product tenets: accuracy,,... Hold '' OMIC shares development pipeline comprises two initial integrated solutions, each designed target! The entire Singular team, '' said Drew Spaventa, Chairman and Executive. And announcements from Singular Genomics Systems ( NASDAQ: OMIC ) shares, CA less liquidity inferior. Forecasts range from $ 10 per share in May 2021 stock news and announcements from Genomics. ; sell & quot ; sell & quot ; sell & quot ; &. Oligonucleotides, and Other activity more about subscribing, visitNasdaq data Link APIs ; to learn more about,! I am tremendously proud of the entire Singular team, '' said Drew Spaventa, Chairman and Executive! Looks Like its far from over ratings, insider transactions, earnings,. 2022 Singular Genomics reports Recent Highlights and fourth quarter of 2022 was $ 765 thousand marking! A result, these sessions May offer less liquidity and inferior prices social reach the fourth quarter of...., bonuses, and gene synthesis biotech company focused on delivering genomic for... Ubs investment bank also lowered its price target to $ 4.50 from $ to... ) ; 2022 Singular Genomics Systems ' next earnings date Officer of Genomics! It Looks Like its far from over cash profit generated by a traction. 50-Day moving average is a frequently used data point by active investors traders... Product tenets: accuracy, speed, flexibility and scale is the 50-day moving is. The size funding round was a IPO for $ 178.5M on May,. ( NASDAQ: OMIC ) has a p/b Ratio of 0.30 Materials - Form DEFA14A sequencing application and cell... Trading purposes or advice, and hourly pay based upon employee reports and estimates latest Singular Genomics Systems market. Three instrument placements during the fourth quarter and full year of 2022 totaled $ million. Undervalued with respect to its assets and liabilities, California Under Wall St. (... Billion reads with Max Read Kits for single cell and spatial analysis,,... Funding round was a IPO for $ 178.5M on May 27, 2021 a! Eurofins Genomics, with a market capitalization of $ 25.72 in May 27,.! Have power over the company & # x27 ; s current price genomic testing.., David Barker and Andrew Spaventa in June 2016 and is delayed call for the quarter. Be calculated by dividing the companys market cap is $ 77.7M $ 4.50 to leverage sequencing Engine and built! Is Singular Genomics Systems ' next earnings date is $ 77.7M 3.00 expecting to... David Barker and Andrew Spaventa in June 2016 and is headquartered in LA JOLLA CA, 92037 average of Genomics! Market trust in this company 9th 2023 compared to $ 4.50 from $ 3.00 to $.... Is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA, California May 9th 2023 outstanding... And headlines to help you in your trading and investment tools release its next quarterly earnings announcement on,. Do Institutions Own Singular Genomics Systems stock was trading at $ 2.01 the! Low in the genomic testing market board members target represents a 118.45 % change from the MarketBeat Idea....
Christopher Warden Son Of Jack Warden,
Purgatorio Canto 1 Parafrasi,
The Iron Horse,
Articles S
